Literature DB >> 33403473

Atypical choroidal nevus in a subject with a germline PALB2 pathogenic variant.

Timothy W Grosel1, Matthew Karl1, Robert T Pilarski2, Frederick H Davidorf1, Mohamed H Abdel-Rahman1,2, Colleen M Cebulla3,4.   

Abstract

Recent evidence suggests that PALB2 variants may increase risk for the development of uveal melanoma and uveal melanocytic neoplasms. Here we report a case of an atypical choroidal nevus in a patient with a personal history of cancer and pathogenic PALB2 germline variant. A 75-year-old white female presented with an elevated predominantly amelanotic choroidal lesion OS. On examination and ophthalmic imaging, the mass measured 8.8 mm × 6.5 mm × 1.5 mm. The mass showed predominantly medium to high reflectivity on diagnostic A-scan and acoustic hollowing on B-scan. OCT over the lesion showed no subretinal fluid. The patient has a personal history of breast cancer and gastric adenoma and a strong family history of cancer. The patient was found to have a pathogenic truncating variant in PALB2 (rs118203998 c.3549C > A, p.Y1183*). Together with our previous findings of pathogenic PALB2 variants in uveal melanoma patients, this new finding of an atypical choroidal nevus in a patient with a pathogenic PALB2 germline variant suggests that pathogenic PALB2 variants may be a risk factor for uveal melanocytic neoplasms. This finding warrants further assessment of the prevalence and progression of uveal melanocytic neoplasms in PALB2 pathogenic variant carriers.
© 2021. Springer Nature B.V.

Entities:  

Keywords:  Atypical choroidal nevus; Germline; PALB2; Uveal melanoma

Mesh:

Substances:

Year:  2021        PMID: 33403473      PMCID: PMC8257753          DOI: 10.1007/s10689-020-00220-2

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  17 in total

Review 1.  Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

Authors:  Sebastian Walpole; Antonia L Pritchard; Colleen M Cebulla; Robert Pilarski; Meredith Stautberg; Frederick H Davidorf; Arnaud de la Fouchardière; Odile Cabaret; Lisa Golmard; Dominique Stoppa-Lyonnet; Erin Garfield; Ching-Ni Njauw; Mitchell Cheung; Joni A Turunen; Pauliina Repo; Reetta-Stiina Järvinen; Remco van Doorn; Martine J Jager; Gregorius P M Luyten; Marina Marinkovic; Cindy Chau; Miriam Potrony; Veronica Höiom; Hildur Helgadottir; Lorenza Pastorino; William Bruno; Virginia Andreotti; Bruna Dalmasso; Giulia Ciccarese; Paola Queirolo; Luca Mastracci; Karin Wadt; Jens Folke Kiilgaard; Michael R Speicher; Natasha van Poppelen; Emine Kilic; Rana'a T Al-Jamal; Irma Dianzani; Marta Betti; Carsten Bergmann; Sandro Santagata; Sonika Dahiya; Saleem Taibjee; Jo Burke; Nicola Poplawski; Sally J O'Shea; Julia Newton-Bishop; Julian Adlard; David J Adams; Anne-Marie Lane; Ivana Kim; Sonja Klebe; Hilary Racher; J William Harbour; Michael L Nickerson; Rajmohan Murali; Jane M Palmer; Madeleine Howlie; Judith Symmons; Hayley Hamilton; Sunil Warrier; William Glasson; Peter Johansson; Carla Daniela Robles-Espinoza; Raul Ossio; Annelies de Klein; Susana Puig; Paola Ghiorzo; Maartje Nielsen; Tero T Kivelä; Hensin Tsao; Joseph R Testa; Pedram Gerami; Marc-Henri Stern; Brigitte Bressac-de Paillerets; Mohamed H Abdel-Rahman; Nicholas K Hayward
Journal:  J Natl Cancer Inst       Date:  2018-12-01       Impact factor: 13.506

Review 2.  Estimating the risk of malignant transformation of a choroidal nevus.

Authors:  Arun D Singh; Partho Kalyani; Allan Topham
Journal:  Ophthalmology       Date:  2005-10       Impact factor: 12.079

3.  PALB2 mutations in familial breast and pancreatic cancer.

Authors:  Erin W Hofstatter; Susan M Domchek; Alexander Miron; Judy Garber; Molin Wang; Kathryn Componeschi; Leigh Boghossian; Penelope L Miron; Katherine L Nathanson; Nadine Tung
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

4.  Germline BAP1 alterations in familial uveal melanoma.

Authors:  Karan Rai; Robert Pilarski; Getachew Boru; Muneeb Rehman; Ahmad H Saqr; James B Massengill; Arun Singh; Meghan J Marino; Frederick H Davidorf; Colleen M Cebulla; Mohamed H Abdel-Rahman
Journal:  Genes Chromosomes Cancer       Date:  2016-10-26       Impact factor: 5.006

5.  CHOROIDAL NEVUS IMAGING FEATURES IN 3,806 CASES AND RISK FACTORS FOR TRANSFORMATION INTO MELANOMA IN 2,355 CASES: The 2020 Taylor R. Smith and Victor T. Curtin Lecture.

Authors:  Carol L Shields; Lauren A Dalvin; David Ancona-Lezama; Michael D Yu; Maura Di Nicola; Basil K Williams; J Antonio Lucio-Alvarez; Su Mae Ang; Sean Maloney; R Joel Welch; Jerry A Shields
Journal:  Retina       Date:  2019-10       Impact factor: 4.256

6.  Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.

Authors:  Siân Jones; Ralph H Hruban; Mihoko Kamiyama; Michael Borges; Xiaosong Zhang; D Williams Parsons; Jimmy Cheng-Ho Lin; Emily Palmisano; Kieran Brune; Elizabeth M Jaffee; Christine A Iacobuzio-Donahue; Anirban Maitra; Giovanni Parmigiani; Scott E Kern; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; James R Eshleman; Michael Goggins; Alison P Klein
Journal:  Science       Date:  2009-03-05       Impact factor: 47.728

7.  Incidence of uveal melanoma in the United States: 1973-1997.

Authors:  Arun D Singh; Allan Topham
Journal:  Ophthalmology       Date:  2003-05       Impact factor: 12.079

8.  Size overlap between benign melanocytic choroidal nevi and choroidal malignant melanomas.

Authors:  James J Augsburger; Zélia M Corrêa; Nikolaos Trichopoulos; Adeel Shaikh
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-11       Impact factor: 4.799

Review 9.  Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions.

Authors:  Beatrice Y Brewington; Yusra F Shao; Fredrick H Davidorf; Colleen M Cebulla
Journal:  Clin Ophthalmol       Date:  2018-05-17

10.  A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor.

Authors:  Amélie Rodrigue; Guillaume Margaillan; Thiago Torres Gomes; Yan Coulombe; Gemma Montalban; Simone da Costa E Silva Carvalho; Larissa Milano; Mandy Ducy; Giuliana De-Gregoriis; Graham Dellaire; Wilson Araújo da Silva; Alvaro N Monteiro; Marcelo A Carvalho; Jacques Simard; Jean-Yves Masson
Journal:  Nucleic Acids Res       Date:  2019-11-18       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.